Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Medingenii Capital is a venture capital firm established to advance healthcare by cultivating companies that provide innovative products and technology. Founded in Houston, Texas, the firm comprises a diverse team of physicians and entrepreneurs who bring a wealth of experience to the table. The firm has made significant strides in the healthcare sector, focusing on early-stage investments that address critical challenges.
Currently, Medingenii Capital manages a portfolio of 100 mentor companies and has completed 65 investments. The firm is actively involved in five angel networks and five international accelerators, showcasing its commitment to fostering innovation both locally and globally. Their strong connections within the Texas Medical Center ecosystem further enhance their ability to scale companies and drive substantial exits.
Medingenii Capital targets early-stage companies that offer disruptive solutions to challenges in healthcare. Their investment strategy encompasses several key sectors, including Health Information Technology, Genomic Testing, Patient Engagement, and Medical Devices. The firm typically invests in the Pre-seed, Seed, and Seed+ stages, allowing them to support startups from their inception through early growth phases.
Check sizes vary depending on the specific needs of the startup, but the firm emphasizes the importance of leveraging their domain expertise and connections within the Texas Medical Center ecosystem. This approach not only aids in scaling companies but also enhances the potential for substantial exits. Medingenii Capital seeks founders who demonstrate a strong vision and the ability to execute innovative ideas in the healthcare space.
Medingenii Capital boasts a diverse portfolio of 100 mentor companies, reflecting its extensive involvement in the healthcare startup ecosystem. The firm has made 65 investments across various sectors, focusing on companies that provide innovative solutions to pressing healthcare challenges. Some notable areas of investment include:
In addition to its investment activities, Medingenii Capital is involved in five angel networks and five international accelerators, further solidifying its presence in the healthcare innovation landscape.
Gen Fukunaga - General Partner. Gen has extensive experience in venture capital and healthcare, having led multiple successful investments in the sector.
Greg Campbell - Managing Partner. Greg brings a wealth of knowledge in healthcare technology and has a strong track record of supporting early-stage companies.
Diane Yoo - Managing Partner. Diane specializes in medical devices and has played a pivotal role in several notable investments.
Eddie Patton - General Partner. Eddie has a background in healthcare entrepreneurship and is known for his strategic insights into market trends.
Sreedhar Mandayam - General Partner. Sreedhar focuses on genomic testing and has significant expertise in scaling healthcare startups.
To pitch Medingenii Capital, founders should use the preferred channel available on their website at medingenii.com. It is advisable to include a comprehensive deck that outlines the business model, market opportunity, and team qualifications. Response times may vary, but founders can expect timely feedback on their submissions.
In recent months, Medingenii Capital has actively expanded its portfolio, completing 65 investments across various healthcare sectors. The firm continues to strengthen its presence in the healthcare startup ecosystem through participation in five angel networks and five international accelerators. These initiatives highlight their commitment to fostering innovation and supporting early-stage companies.
Additionally, Medingenii Capital has been involved in discussions regarding potential partnerships with other healthcare platforms, aiming to enhance access to innovative solutions and drive impactful investments in the industry.
What are Medingenii Capital's investment criteria?
Medingenii Capital focuses on early-stage companies in the healthcare sector, particularly those offering disruptive solutions in Health Information Technology, Genomic Testing, Patient Engagement, and Medical Devices. They seek startups that demonstrate strong leadership and innovative ideas.
How can I apply or pitch to Medingenii Capital?
Founders can pitch their ideas through the firm's website at medingenii.com. It is recommended to include a clear business model, market analysis, and details on the team in the pitch deck.
What makes Medingenii Capital different from other investors?
Medingenii Capital leverages its deep connections within the Texas Medical Center ecosystem, providing portfolio companies with unique access to resources and expertise that can significantly enhance their growth potential.
What is the geographic scope of Medingenii Capital's investments?
The firm primarily invests in North America, specifically focusing on the United States, which allows them to tap into a robust healthcare market.
What is the typical check size for investments?
While specific check sizes are not disclosed, Medingenii Capital invests in the Pre-seed, Seed, and Seed+ stages, indicating a flexible approach to funding based on the needs of the startup.
What kind of post-investment involvement does Medingenii Capital have?
Medingenii Capital actively engages with its portfolio companies, providing mentorship, operational support, and access to their extensive network within the healthcare sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.